Pharmacokinetically modified human serum albumin based therapeutic design and development
Human serum albumin (HSA) is synthesized predominantly in the liver, and has an extraordinarily long circulatory half-life (~19 days). Since HSA is responsible for 80% of the colloidal osmotic pressure of plasma, the patients with hypoalbuminemia are typically given a plasma expander to increase the...
| Main Authors: | , , , |
|---|---|
| Format: | Book Chapter |
| Published: |
2015
|
| Online Access: | http://hdl.handle.net/20.500.11937/46904 |